Noah Davidsohn is the Chief Scientific Officer (CSO) and co-founder of Rejuvenate Bio. He has a strong background in gene therapy and biotechnology, with a focus on developing treatments for age-related diseases. Noah's work at Rejuvenate Bio includes pioneering gene therapies that target chronic diseases and aging-related conditions. His innovative approach combines animal and human health programs, leveraging similarities in therapeutic targets while addressing regulatory and market challenges

Rewinding Time: How Reprogramming Cells Could Cure Disease

To be announced

http://rejuvenatebio.com